Printer Friendly
The Free Library
14,716,216 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Salix Pharmaceuticals to Present at Wachovia Securities Healthcare Conference.


RALEIGH, N.C. -- Salix Pharmaceuticals, Ltd. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:SLXP) today announced that the Company will present at the Wachovia Securities 2007 Healthcare Conference in Boston, MA on Wednesday, January 31, 2007 at 10:15 a.m. ET.

Interested parties can access a live audio web cast of this presentation at http://www.salix.com. A replay of this presentation will be available at the same location.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina For other uses of this name, see Raleigh.
Raleigh (IPA: /ˈrɑli/, ral-ee) is the capital of the State of North Carolina and the county seat of Wake County.
, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's gastroenterology gastroenterology

Medical specialty dealing with digestion and the digestive system. In the 17th century Jan Baptista van Helmont conducted the first scientific studies in the field; William Beaumont published his own observations in 1833.
 specialty sales and marketing team. Salix markets COLAZAL([R]), XIFAXAN([R]), OSMOPREP[TM], VISICOL([R]), MOVIPREP([R]), AZASAN([R]), ANUSOL-HC([R]) and PROCTOCORT([R]). Balsalazide tablets, Granulated gran·u·late  
v. gran·u·lat·ed, gran·u·lat·ing, gran·u·lates

v.tr.
1. To form into grains or granules.

2. To make rough and grainy.

v.intr.
 Mesalamine, SANVAR([R]) (600 ug vials vapreotide acetate powder) and Xifaxan for additional indications are under development.

Salix trades on the NASDAQ Global Market under the ticker symbol Ticker Symbol

An arrangement of characters (usually letters) representing a particular security listed on an exchange or otherwise traded publicly. When a company issues securities to the public marketplace, it selects an available ticker symbol for its securities which investors
 "SLXP".

For more information please contact the Company at 919-862-1000 or visit our web site at www.salix.com. Information on our web site is not incorporated in our SEC filings.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 24, 2007
Words:199
Previous Article:Research and Markets: JETWAY Information Co., Ltd.: 2006 Contract Manufacturing Profile Covers Areas Such As General Company Information, Company...
Next Article:Accenture Opens New Delivery Center in Brno, Czech Republic.
Topics:



Related Articles
Salix Pharmaceuticals Board Unanimously Recommends Rejection of Axcan's Unsolicited Tender Offer.
Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference.
Salix Pharmaceuticals to Present at Rodman & Renshaw Global Healthcare Conference.
Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference.
Salix Pharmaceuticals to Present at CIBC Conference.
Salix Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference.
ProEthic to Present at Wachovia Securities Small and Mid-Cap Healthcare Conference.
Salix Pharmaceuticals to Present at Two Investment Conferences During March.
Salix Pharmaceuticals to Present At CIBC World Markets Conference.
Salix Pharmaceuticals to Present at Three Investment Conferences During May and June.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles